Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study.

Chiara Fabbri,Siegfried Kasper,Joseph Zohar,Daniel Souery,Stuart Montgomery,Diego Albani,Gianluigi Forloni,Panagiotis Ferentinos,Dan Rujescu,Julien Mendlewicz,Diana De Ronchi,Marco Andrea Riva,Cathryn M Lewis,Alessandro Serretti

Progress in Neuro-Psychopharmacology and Biological Psychiatry（2021）

引用 18|浏览67

暂无评分

摘要

About 20–30% of patients with major depressive disorder (MDD) develop treatment-resistant depression (TRD) and finding new effective treatments for TRD has been a challenge. This study aimed to identify new possible pharmacological options for TRD.

查看译文

关键词

Treatment-resistant depression,Drug repurposing,Pharmacogenetics,Major depression

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要